Active Surveillance Cultures and Decolonization to Reduce Staphylococcus aureus Infections in the Neonatal Intensive Care Unit.

Victor O Popoola, Elizabeth Colantuoni, Nuntra Suwantarat, Rebecca Pierce, Karen C Carroll, Susan W Aucott, Aaron M Milstone
Author Information
  1. Victor O Popoola: 1Division of Pediatric Infectious Diseases,Department of Pediatrics,Johns Hopkins University School of Medicine,Baltimore,Maryland.
  2. Elizabeth Colantuoni: 2Department of Biostatistics,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland.
  3. Nuntra Suwantarat: 3Division of Medical Microbiology,Department of Pathology,Johns Hopkins University School of Medicine,Baltimore,Maryland.
  4. Rebecca Pierce: 4Department of Epidemiology,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland.
  5. Karen C Carroll: 4Department of Epidemiology,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland.
  6. Susan W Aucott: 5Division of Neonatology,Department of Pediatrics,Johns Hopkins University School of Medicine,Baltimore,Maryland.
  7. Aaron M Milstone: 1Division of Pediatric Infectious Diseases,Department of Pediatrics,Johns Hopkins University School of Medicine,Baltimore,Maryland.

Abstract

BACKGROUND: Staphylococcus aureus is a common cause of healthcare-associated infections in neonates.
OBJECTIVE: To examine the impact of methicillin-susceptible S. aureus (MSSA) decolonization on the incidence of MSSA infection and to measure the prevalence of mupirocin resistance.
METHODS: We retrospectively identified neonates admitted to a tertiary care neonatal intensive care unit (NICU) from April 1, 2011, through September 30, 2014. We compared rates of MSSA-positive cultures and infections before and after implementation of an active surveillance culture and decolonization intervention for MSSA-colonized neonates. We used 2 measurements to identify the primary outcome, NICU-attributable MSSA: (1) any culture sent during routine clinical care that grew MSSA and (2) any culture that grew MSSA and met criteria of the National Healthcare Safety Network's healthcare-associated infection surveillance definitions. S. aureus isolates were tested for mupirocin susceptibility. We estimated incidence rate ratios using interrupted time-series models.
RESULTS: Before and after the intervention, 1,523 neonates (29,220 patient-days) and 1,195 neonates (22,045 patient-days) were admitted to the NICU, respectively. There was an immediate reduction in the mean quarterly incidence rate of NICU-attributable MSSA-positive clinical cultures of 64% (incidence rate ratio, 0.36 [95% CI, 0.19-0.70]) after implementation of the intervention, and MSSA-positive culture rates continued to decrease by 21% per quarter (incidence rate ratio, 0.79 [95% CI, 0.74-0.84]). MSSA infections also decreased by 73% immediately following the intervention implementation (incidence rate ratio, 0.27 [95% CI, 0.10-0.79]). No mupirocin resistance was detected.
CONCLUSION: Active surveillance cultures and decolonization may be effective in decreasing S. aureus infections in NICUs.

References

  1. Eur J Pediatr. 2007 Apr;166(4):319-25 [PMID: 17051356]
  2. J Hosp Infect. 2000 Oct;46(2):123-9 [PMID: 11049705]
  3. J Perinatol. 2013 Apr;33(4):313-8 [PMID: 22918547]
  4. J Perinatol. 2010 Feb;30(2):135-9 [PMID: 19710681]
  5. JAMA Pediatr. 2015 Dec;169(12):1105-11 [PMID: 26502073]
  6. Infect Control Hosp Epidemiol. 2012 Dec;33(12):1200-6 [PMID: 23143356]
  7. Pediatrics. 2011 Aug;128(2):e348-57 [PMID: 21768312]
  8. Infect Control Hosp Epidemiol. 2010 May;31(5):558-60 [PMID: 20334509]
  9. Public Health Rep. 2007 Mar-Apr;122(2):160-6 [PMID: 17357358]
  10. Infect Control Hosp Epidemiol. 2002 Nov;23(11):677-82 [PMID: 12452296]
  11. Infect Control Hosp Epidemiol. 2006 Feb;27(2):139-45 [PMID: 16465630]
  12. J Perinatol. 2014 Nov;34(11):803-4 [PMID: 25359411]
  13. Infect Control Hosp Epidemiol. 2003 May;24(5):342-6 [PMID: 12785407]
  14. JAMA. 2004 Nov 17;292(19):2357-65 [PMID: 15547163]
  15. J Clin Microbiol. 2015 Aug;53(8):2492-501 [PMID: 26019206]
  16. J Hosp Infect. 2012 Sep;82(1):56-7 [PMID: 22854355]
  17. Pediatrics. 2004 Aug;114(2):348-55 [PMID: 15286215]
  18. Infect Control Hosp Epidemiol. 2015 Feb;36(2):232-4 [PMID: 25633010]
  19. J Perinatol. 2014 Nov;34(11):805-10 [PMID: 25010222]
  20. Infect Control Hosp Epidemiol. 2012 Oct;33(10):1024-30 [PMID: 22961022]
  21. J Perinatol. 2014 Sep;34(9):653-5 [PMID: 25010223]
  22. Pediatrics. 2002 Aug;110(2 Pt 1):285-91 [PMID: 12165580]
  23. PLoS One. 2011;6(8):e23001 [PMID: 21857979]
  24. J Pediatr. 2001 Dec;139(6):821-7 [PMID: 11743507]
  25. Infect Control Hosp Epidemiol. 1996 Dec;17(12):811-3 [PMID: 8985769]
  26. Early Hum Dev. 2012 May;88 Suppl 2:S69-74 [PMID: 22633519]
  27. Infect Control Hosp Epidemiol. 2014 Apr;35(4):412-8 [PMID: 24602947]
  28. Pediatrics. 2012 Apr;129(4):e914-22 [PMID: 22412036]
  29. N Engl J Med. 2013 Jun 13;368(24):2255-65 [PMID: 23718152]
  30. Infect Control Hosp Epidemiol. 2005 Jul;26(7):616-21 [PMID: 16092741]
  31. Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S108-32 [PMID: 25376072]
  32. Clin Infect Dis. 2007 Sep 1;45(5):541-7 [PMID: 17682986]

Grants

  1. R03 AI117169/NIAID NIH HHS
  2. UL1 RR025005/NCRR NIH HHS
  3. R01HS022872/AHRQ HHS
  4. R01 HS022872/AHRQ HHS
  5. R03AI117169/NIAID NIH HHS

MeSH Term

Anti-Bacterial Agents
Cross Infection
Female
Humans
Incidence
Infant, Newborn
Infection Control
Intensive Care Units, Neonatal
Male
Maryland
Methicillin-Resistant Staphylococcus aureus
Mupirocin
Regression Analysis
Retrospective Studies
Staphylococcal Infections
Tertiary Healthcare

Chemicals

Anti-Bacterial Agents
Mupirocin

Word Cloud

Created with Highcharts 10.0.0incidence0aureusneonatesMSSArateinfections1cultureinterventionSdecolonizationmupirocincareMSSA-positiveculturesimplementationsurveillanceratio[95%CIStaphylococcushealthcare-associatedinfectionresistanceadmittedNICUrates2NICU-attributableclinicalgrewpatient-daysActiveBACKGROUND:commoncauseOBJECTIVE:examineimpactmethicillin-susceptiblemeasureprevalenceMETHODS:retrospectivelyidentifiedtertiaryneonatalintensiveunitApril2011September302014comparedactiveMSSA-colonizedusedmeasurementsidentifyprimaryoutcomeMSSA:sentroutinemetcriteriaNationalHealthcareSafetyNetwork'sdefinitionsisolatestestedsusceptibilityestimatedratiosusinginterruptedtime-seriesmodelsRESULTS:5232922019522045respectivelyimmediatereductionmeanquarterly64%3619-070]continueddecrease21%perquarter7974-084]alsodecreased73%immediatelyfollowing2710-079]detectedCONCLUSION:mayeffectivedecreasingNICUsSurveillanceCulturesDecolonizationReduceInfectionsNeonatalIntensiveCareUnit

Similar Articles

Cited By